Therapeutically, PtpB-MIP demonstrates dual anti-inflammatory and immunoregulatory properties, positioning it as a promising candidate for managing inflammatory and autoimmune disorders, contrasting with strategies targeting PtpB-Mtb inhibition to restore antimicrobial defenses [23]. This evidence concerns the gene MIP and autoimmune disease.